HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.

AuthorsG Mathé, M A Gil, M Delgado, M Bayssas, J Gouveia, P Ribaud, D Machover, J L Misset, F de Vassal, L Schwarzenberg, C Jasmin, M Hayat
JournalRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (Recent Results Cancer Res) Vol. 74 Pg. 217-22 ( 1980) ISSN: 0080-0015 [Print] Germany
PMID6893752 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Naphthacenes
  • aclacinomycins
  • Aclarubicin
Topics
  • Aclarubicin (analogs & derivatives)
  • Adolescent
  • Adult
  • Aged
  • Antibiotics, Antineoplastic (adverse effects, therapeutic use)
  • Child
  • Drug Evaluation
  • Female
  • Humans
  • Leukemia (drug therapy)
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Male
  • Middle Aged
  • Naphthacenes (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: